• Primary Hyperoxaluria Gene Mutation Panel
  • Respiratory Pathogen (Pneumonia) Panel with Antibiotic Resistance Genes, Molecular
  • Transthyretin (TTR) Gene Mutation Analysis
  • Renin Activity
  • Valproic Acid, Free and Total, Serum
  • Inhibin A
  • Influenza Virus Type A and B, PCR
  • 15q Deletion, Type I and Type II Characterization, Prader-Willi/Angelman Syndromes, FISH
  • Valproic Acid, Free, Serum
  • Alprazolam, SerumĀ 
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
Medical Test

Clinical Utility
Access to CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2) is restricted.